Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Liver Function, Immunoassays & Nucleic Acid Assays, Imaging, Liver Biopsy), And Segment Forecasts, 2018 - 2025
This report can be delivered to the clients within 48 Hours
The global hepatitis diagnostics market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. In the past decade, the burden of hepatitis A, B & C has significantly increased compared to that of type D & E. In addition, in emerging countries, around 90% of the children (below 10 years of age) are infected with type A virus as stated by the WHO reports. These reports also state that in 2016, around 71 million people were affected by the hepatitis C and 257 million people were suffering from type B infection.
The non-government and government organizations play a vital role in increasing awareness of infectious diseases by conducting campaigns in order to deliver correct knowledge about the symptoms, condition, and detection techniques. Thereby, rendering a positive impact on the market growth owing to rising demand for diagnostic tests. Furthermore, the adoption of molecular biology techniques and other technologically advanced detection techniques are spurring the market growth.
Further key findings from the study suggest:
The global hepatitis diagnostics market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. In the past decade, the burden of hepatitis A, B & C has significantly increased compared to that of type D & E. In addition, in emerging countries, around 90% of the children (below 10 years of age) are infected with type A virus as stated by the WHO reports. These reports also state that in 2016, around 71 million people were affected by the hepatitis C and 257 million people were suffering from type B infection.
The non-government and government organizations play a vital role in increasing awareness of infectious diseases by conducting campaigns in order to deliver correct knowledge about the symptoms, condition, and detection techniques. Thereby, rendering a positive impact on the market growth owing to rising demand for diagnostic tests. Furthermore, the adoption of molecular biology techniques and other technologically advanced detection techniques are spurring the market growth.
Further key findings from the study suggest:
- The blood tests segment dominate the market and is expected to exhibit the fastest growth rate over the forecast period owing to their higher adoption as a first line of diagnosis.
- The liver function tests, sub type of blood test hold a significant share of the market since these tests are the first line diagnostics and are prerequisite for further analytical examinations required to performed for confirmation of virus causing the disease
- North America dominated with largest revenue share in 2016, owing to rising prevalence, various government initiatives creating awareness regarding rising incidences, and highly developed healthcare infrastructure
- Constant rise in the new cases of hepatitis is observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
- Some of the major players competing include, but are not limited to Abbott Laboratories; Danaher Corporation; F. Hoffmann Roche; DiaSorin S.p.A; MedMira, Inc.; Siemens Ag, bioMeriuex SA; Hologic, Inc.; and Bio Rad Laboratories.
- These players dominate the market with their strong brand identity and extensive geographic reach by their strategic initiatives such as mergers & acquisition and partnership with other players.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information procurement
1.2 Data Analysis
1.3 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 HEPATITIS DIAGNOSTIC MARKET VARIABLES, TRENDS & SCOPE
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.2 Market Restraint Analysis
3.2 Penetration & growth prospect mapping
3.3 Hepatitis Diagnostics Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
CHAPTER 4 HEPATITIS DIAGNOSTIC MARKET: TEST TYPE ESTIMATES & TREND ANALYSIS
4.1 Hepatitis diagnostics market: Tests type movement analysis
4.2 Blood Tests
4.2.1 Blood Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
4.2.2 Liver Function Tests
4.2.2.1 L Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.2.3 Immunoassays
4.2.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.2.4 Nucleic Acid Tests
4.2.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.3 Imaging Test
4.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.4 Liver Biopsy
4.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
CHAPTER 5 HEPATITIS DIAGNOSTIC MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY DIAGNOSTIC TESTS
5.1 Hepatitis Diagnostic market share by region, 2015 & 2024
5.2 North America
5.2.1 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.3.2 UK
5.3.2.1 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific hepatitis diagnostic market, 2014 - 2025 (USD Million)
5.4.2 China
5.4.2.1 China hepatitis diagnostic market, 2014 - 2025 (USD Million)
5.4.3 Japan
5.4.3.1 Japan hepatitis diagnostic market, 2014 - 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.5.2 B razil
5.5.2.1Brazil hepatitis diagnosticmarket, 2014 - 2025 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.6 MEA
5.6.1 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Siemens AG
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Abbott Laboratories
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 MedMira Inc
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 Qaigen Inc
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 Beckman Coulter Inc (Danaher Corporation)
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
6.1.6 F. Hoffmann Roche
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.1 Product benchmarking
6.1.6.4 Strategic initiatives
6.1.7 Diasorin S.p.A
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic initiatives
6.1.8 bioMeriuex
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 Hologic Inc
6.1.9.1 Company overview
6.1.9.2 Financial performance
6.1.9.3 Product benchmarking
6.1.9.4 Strategic initiatives
6.1.10 Bio-Rad Laboratories Inc
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Product benchmarking
6.1.10.4 Strategic initiatives
1.1 Information procurement
1.2 Data Analysis
1.3 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 HEPATITIS DIAGNOSTIC MARKET VARIABLES, TRENDS & SCOPE
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.2 Market Restraint Analysis
3.2 Penetration & growth prospect mapping
3.3 Hepatitis Diagnostics Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
CHAPTER 4 HEPATITIS DIAGNOSTIC MARKET: TEST TYPE ESTIMATES & TREND ANALYSIS
4.1 Hepatitis diagnostics market: Tests type movement analysis
4.2 Blood Tests
4.2.1 Blood Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
4.2.2 Liver Function Tests
4.2.2.1 L Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.2.3 Immunoassays
4.2.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.2.4 Nucleic Acid Tests
4.2.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.3 Imaging Test
4.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.4 Liver Biopsy
4.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
CHAPTER 5 HEPATITIS DIAGNOSTIC MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY DIAGNOSTIC TESTS
5.1 Hepatitis Diagnostic market share by region, 2015 & 2024
5.2 North America
5.2.1 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.3.2 UK
5.3.2.1 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific hepatitis diagnostic market, 2014 - 2025 (USD Million)
5.4.2 China
5.4.2.1 China hepatitis diagnostic market, 2014 - 2025 (USD Million)
5.4.3 Japan
5.4.3.1 Japan hepatitis diagnostic market, 2014 - 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.5.2 B razil
5.5.2.1Brazil hepatitis diagnosticmarket, 2014 - 2025 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.6 MEA
5.6.1 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Siemens AG
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Abbott Laboratories
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 MedMira Inc
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 Qaigen Inc
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 Beckman Coulter Inc (Danaher Corporation)
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
6.1.6 F. Hoffmann Roche
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.1 Product benchmarking
6.1.6.4 Strategic initiatives
6.1.7 Diasorin S.p.A
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic initiatives
6.1.8 bioMeriuex
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 Hologic Inc
6.1.9.1 Company overview
6.1.9.2 Financial performance
6.1.9.3 Product benchmarking
6.1.9.4 Strategic initiatives
6.1.10 Bio-Rad Laboratories Inc
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Product benchmarking
6.1.10.4 Strategic initiatives
LIST OF TABLES
TABLE 1 North America Hepatitis Diagnostics Market, by Test Type, 2014 - 2025 (USD Million)
TABLE 2 North America Hepatitis Diagnostics Market, by Blood Tests Market, 2014 - 2025 (USD Million)
TABLE 3 U.S. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 4 U.S. hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
TABLE 5 Canada hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 6 Canada hepatitis diagnostic, by blood tests, 2014 - 2025 (USD Million)
TABLE 7 Europe hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 8 Europe hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 9 U.K. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 10 U.K. hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 11 Germany hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 12 Germany hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 13 Asia Pacific hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 14 Asia Pacific hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
TABLE 15 China hepatitis diagnostic market, by test type, 2014 - 2025 (USD Million)
TABLE 16 China hepatitis diagnostic tests market, by blood tests 2014 - 2025 (USD Million)
TABLE 17 Japan hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 18 Japan hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 19 Latin America hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 20 Latin America hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
TABLE 21 Brazil hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
TABLE 22 Brazil hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
TABLE 23 Mexico hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
TABLE 24 Mexico hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
TABLE 25 MEA hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 26 MEA hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 27 South Africa hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
TABLE 28 South Africa hepatitis diagnostics market, by blood test 2014 - 2025 (USD Million)
TABLE 1 North America Hepatitis Diagnostics Market, by Test Type, 2014 - 2025 (USD Million)
TABLE 2 North America Hepatitis Diagnostics Market, by Blood Tests Market, 2014 - 2025 (USD Million)
TABLE 3 U.S. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 4 U.S. hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
TABLE 5 Canada hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 6 Canada hepatitis diagnostic, by blood tests, 2014 - 2025 (USD Million)
TABLE 7 Europe hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 8 Europe hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 9 U.K. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 10 U.K. hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 11 Germany hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 12 Germany hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 13 Asia Pacific hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 14 Asia Pacific hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
TABLE 15 China hepatitis diagnostic market, by test type, 2014 - 2025 (USD Million)
TABLE 16 China hepatitis diagnostic tests market, by blood tests 2014 - 2025 (USD Million)
TABLE 17 Japan hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 18 Japan hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 19 Latin America hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 20 Latin America hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
TABLE 21 Brazil hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
TABLE 22 Brazil hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
TABLE 23 Mexico hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
TABLE 24 Mexico hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
TABLE 25 MEA hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 26 MEA hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
TABLE 27 South Africa hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
TABLE 28 South Africa hepatitis diagnostics market, by blood test 2014 - 2025 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 Hepatitis Diagnostic s Market PESTLE Analysis
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Hepatitis Diagnostics market drug class outlook key takeaways
FIG. 16 Hepatitis diagnostic market: test type movement analysis
FIG. 17 Blood test market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 18 Liver function tests market estimates & segment forecast market, 2014 - 2025 (USD Million)
FIG. 19 Immunoassay market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 20 Nucleic Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 21 Imaging test market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 22 Liver Biopsy market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 23 Regional market place: Key takeaways
FIG. 24 Regional outlook, 2016 & 2025
FIG. 25 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 26 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 27 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 28 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 29 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 30 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 31 Asia Pacific hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 32 China hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 33 Japan hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 34 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 35 Brazil hepatitis diagnostics market, 2014 - 2025(USD Million)
FIG. 36 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 37 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 38 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 39 Strategy framework
FIG. 40 Participant categorization
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 Hepatitis Diagnostic s Market PESTLE Analysis
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Hepatitis Diagnostics market drug class outlook key takeaways
FIG. 16 Hepatitis diagnostic market: test type movement analysis
FIG. 17 Blood test market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 18 Liver function tests market estimates & segment forecast market, 2014 - 2025 (USD Million)
FIG. 19 Immunoassay market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 20 Nucleic Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 21 Imaging test market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 22 Liver Biopsy market estimates & segment forecast, 2014 - 2025 (USD Million)
FIG. 23 Regional market place: Key takeaways
FIG. 24 Regional outlook, 2016 & 2025
FIG. 25 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 26 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 27 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 28 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 29 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 30 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 31 Asia Pacific hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 32 China hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 33 Japan hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 34 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 35 Brazil hepatitis diagnostics market, 2014 - 2025(USD Million)
FIG. 36 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 37 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 38 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)
FIG. 39 Strategy framework
FIG. 40 Participant categorization
